Reports for MINT PHARMACEUTICALS INC
Company Name
MINT PHARMACEUTICALS INC
Totals |
||
Shortage reports |
132 |
|
Actual shortage: | 30 (23%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 0 (0%) | |
Resolved: | 102 (77%) | |
Discontinuation Reports |
29 |
|
To be discontinued: | 0 (0%) | |
Discontinued: | 29 (100%) | |
Reversed: | 0 (0%) | |
Late reports |
33 (20%) |
|
Overdue reports |
15 (50%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
MINT-IRBESARTAN | 150MG | TABLET | Resolved | 2019-04-08 | 2021-07-12 | 80800 |
MINT-IRBESARTAN | 300MG | TABLET | Resolved | 2019-04-08 | 2021-07-12 | 80803 |
MINT-IRBESARTAN/HCTZ | 12.5MG 150.0MG | TABLET | Resolved | 2019-04-08 | 2021-08-11 | 80792 |
MINT-IRBESARTAN/HCTZ | 12.5MG 300.0MG | TABLET | Resolved | 2019-01-03 | 2019-01-16 | 71060 |
MINT-IRBESARTAN/HCTZ | 12.5MG 300.0MG | TABLET | Resolved | 2019-01-16 | 2021-08-11 | 72666 |
MINT-IRBESARTAN/HCTZ | 25.0MG 300.0MG | TABLET | Resolved | 2019-04-08 | 2021-08-11 | 80797 |
MINT-LACOSAMIDE | 50MG | TABLET | Resolved | 2021-01-11 | 2021-02-23 | 131336 |
MINT-LETROZOLE | 2.5MG | TABLET | Actual shortage | 2024-01-26 | 2024-01-26 | 217372 |
MINT-LEVOCARB | 10MG 100MG | TABLET | Actual shortage | 2017-12-08 | 2017-12-09 | 32263 |
MINT-LEVOCARB | 25MG 100MG | TABLET | Actual shortage | 2017-12-08 | 2017-12-09 | 32270 |
MINT-LEVOCARB | 25MG 250MG | TABLET | Actual shortage | 2017-12-08 | 2017-12-09 | 32274 |
MINT-LOSARTAN | 25.0MG | TABLET | Actual shortage | 2019-01-03 | 2020-01-27 | 71069 |
MINT-LOSARTAN | 50.0MG | TABLET | Resolved | 2019-01-03 | 2019-06-19 | 71074 |
MINT-LOSARTAN | 50.0MG | TABLET | Actual shortage | 2020-04-25 | 2020-04-25 | 113187 |
MINT-LOSARTAN | 100.0MG | TABLET | Resolved | 2019-01-03 | 2019-06-19 | 71066 |
MINT-LOSARTAN | 100.0MG | TABLET | Actual shortage | 2020-04-25 | 2020-04-25 | 113190 |
MINT-LOSARTAN/HCTZ | 12.5MG 50MG | TABLET | Resolved | 2019-02-04 | 2020-01-27 | 74450 |
MINT-LOSARTAN/HCTZ | 50MG 12.5MG | TABLET | Resolved | 2020-04-25 | 2020-07-13 | 113193 |
MINT-LOSARTAN/HCTZ | 12.5MG 50MG | TABLET | Actual shortage | 2021-10-21 | 2023-01-03 | 147784 |
MINT-LOSARTAN/HCTZ | 12.5MG 100MG | TABLET | Resolved | 2019-04-08 | 2020-07-13 | 80808 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
MINT-RIZATRIPTAN ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-06-21 | 2017-07-01 | 13544 |
MINT-RIZATRIPTAN ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-06-21 | 2017-07-01 | 13553 |
MINT-ROSUVASTATIN | 5MG | TABLET | Discontinued | 2019-10-09 | 2019-10-10 | 95897 |
MINT-ROSUVASTATIN | 10MG | TABLET | Discontinued | 2019-10-09 | 2019-10-10 | 95900 |
MINT-ROSUVASTATIN | 20MG | TABLET | Discontinued | 2019-10-09 | 2019-10-10 | 95903 |
MINT-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2019-10-09 | 2019-10-10 | 95907 |
MINT-SOLIFENACIN | 5MG | TABLET | Discontinued | 2019-10-09 | 2019-10-10 | 95913 |
MINT-SOLIFENACIN | 10MG | TABLET | Discontinued | 2019-10-09 | 2019-10-10 | 95916 |
MINT-ZOLMITRIPTAN ODT | 2.5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-06-21 | 2017-07-01 | 13540 |